Clinical Trial Update: Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated Avastin (bevacizumab) in combination with pemetrexed, with or without carboplatin, in elderly patients with non-squamous non-small cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: PD Dr. med. Wolfgang Schuette | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-03-10